Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis
- 20 March 2012
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (10) , 1333-1338
Abstract
Purpose We retrospectively analyzed preoperative levels of carbohydrate antigen (CA) 19-9 in colorectal cancer (CRC) patients to determine the prognostic value of CA19-9 in CRC patients with normal carcinoembryonic antigen (CEA) levels. Methods A total of 639 patients who underwent curative surgery at Taipei Veterans General Hospital between 2002 and 2006 were enrolled. We excluded 254 patients (39.7 %) with high preoperative CEA levels and analyzed 385 patients with normal CEA levels. The measured endpoint was the postoperative disease-free survival (DFS). The prognostic value of CA19-9 was determined using log-rank test and Cox regression analysis. Results High CA19-9 levels were significantly associated with advanced disease and were detected in 5.8 % of patients with stage I disease, 11.7 % of those with stage II disease, and 22.5 % of those with stage III disease (P < 0.001). The 5-year DFS in patients with normal CA19-9 levels was 82.0 %, which was significantly higher than that in patients with high CA19-9 levels (68 %; P < 0.001). In a multivariate analysis, the most important independent factor affecting the 5-year DFS was tumor–node–metastasis stage (95 % CI, 1.26–2.36; HR = 1.72). After stratification by other factors, high CA19-9 level remained an independent prognostic factor for patients with normal CEA levels. Patients with high CA19-9 levels also showed a higher incidence of lung metastasis (23.1 %) than those with normal CA19-9 levels (7.2 %). Conclusions CA19-9 may be a prognostic factor for CRC patients with normal CEA levels. An aggressive follow-up protocol for lung metastasis should be used for these patients.Keywords
This publication has 21 references indexed in Scilit:
- Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancerInternational Journal of Colorectal Disease, 2011
- Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical useEuropean Journal of Cancer, 2007
- ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal CancerJournal of Clinical Oncology, 2006
- Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinomaJournal of Surgical Oncology, 2006
- Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice GuidelineJournal of Clinical Oncology, 2005
- Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?Journal of Surgical Research, 2005
- Clinical utility of biochemical markers in colorectal cancerEuropean Journal of Cancer, 2003
- Are Right- and Left-Sided Colon Neoplasms Distinct Tumors?Digestive Diseases, 1997
- Microsatellite Instability in Cancer of the Proximal ColonScience, 1993
- Comparison of L-selectin and E-selectin ligand specificities: The L-selectin can bind the E-selectin ligands Sialyl Lex and Sialyl LeaBiochemical and Biophysical Research Communications, 1992